Sci Pharmtech Inc. (4119) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sci Pharmtech Inc. (4119:TWSE), powered by AI.

Current Price
$44.20
Sector
Healthcare
What is the Sci Pharmtech Inc. stock price forecast?

Sci Pharmtech Inc. is currently trading at $44.20. View real-time AI analysis on Alpha Lenz.

What is Sci Pharmtech Inc. insider trading activity?

View the latest insider trading data for Sci Pharmtech Inc. on Alpha Lenz.

What is Sci Pharmtech Inc.'s P/E ratio?

View Sci Pharmtech Inc.'s valuation metrics on Alpha Lenz.

Sci Pharmtech Inc.

TWSE · 4119
NT$44.20+0.85(+1.96%)
Ask about Sci Pharmtech Inc.'s future dividend policy...
Alpha Chat Insight

Sci Pharmtech Inc.'s ROE is 2.0%. Explore profitability and growth together.

Ask for details

Company Overview

Sci Pharmtech Inc. is a prominent player in the specialty chemicals sector, primarily focusing on the development and production of Active Pharmaceutical Ingredients (APIs). It serves as a crucial link in the pharmaceutical supply chain by providing high-quality APIs that are essential for the manufacture of a wide range of prescription drugs and healthcare products. Renowned for its rigorous manufacturing standards and R&D capabilities, Sci Pharmtech is instrumental in meeting the stringent regulatory requirements of global health authorities. The company's operations significantly impact the pharmaceutical industry, particularly in areas such as generic medicine production and drug formulation. By maintaining a robust portfolio and leveraging advanced chemical synthesis techniques, Sci Pharmtech plays a vital role in ensuring the availability and affordability of medications across various therapeutic categories. It stands as a strategic partner to pharmaceutical firms worldwide, contributing to the innovation and efficiency of the global healthcare system.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.34BRevenue
0.00Shares Out
0Employees

Margins

26.12%Gross
26.70%EBITDA
11.55%Operating
7.61%Pre-Tax
7.99%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

14.30%Rev 3Yr
-12.96%Rev 5Yr
9.28%Op Inc 3Yr
-31.78%Op Inc 5Yr
-29.68%Net Inc 3Yr
-21.50%Net Inc 5Yr

Returns

1.52%ROA
1.98%ROE
1.52%ROIC

Financial Health

NT$60.63MCash & Cash Equivalents
NT$1.43BNet Debt
27.66%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sci Pharmtech Inc. (ticker: 4119) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 44.2 with a P/E ratio of -x and P/B of -x.

ROE is 1.98% and operating margin is 11.55%. Annual revenue is $1.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sci Pharmtech Inc. (4119) Stock Forecast 2026 $44.20 — Price, Financials & Analyst Targets | Alpha Lenz